BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Deals

  Regulatory Review Holds Up Merck & Co., Inc., Sanofi-Aventis (France) Venture

  March 2, 2011

   · 

  1 min read
• Business

  GTX Corp and Ipsen Terminate Their Toremifene Collaboration

  March 2, 2011

   · 

  3 min read
• Policy

  Merck KGaA’s EMD Serono, Inc. (Billerica)'s MS Drug Cladribine Rejected by FDA

  March 2, 2011

   · 

  5 min read
• Business

  Galapagos NV Delivers Candidate Drug In GlaxoSmithKline Alliance, Receives EUR6.7 Million

  March 2, 2011

   · 

  3 min read
• Career Advice

  Get Yourself Ready For That Upcoming Job Interview

  March 2, 2011

   · 

  1 min read
• Pharm Country

  Palatin Technologies Closes $23 Million Public Offering

  March 2, 2011

   · 

  3 min read
• Oncolytics Biotech Inc. Receives $7.7 Million from Exercise of Warrants

  March 2, 2011

   · 

  3 min read
• BioMidwest

  Centene Corporation to Present at Upcoming Healthcare Conferences

  March 2, 2011

   · 

  1 min read
• Biotech Beach

  New Breast Reconstruction Procedure Demonstrates Long Term Success in European Trial; Data Reported From Cytori Therapeutics, Inc.'s RESTORE-2 Study of the Celution(R) System

  March 2, 2011

   · 

  5 min read
• Drug Development

  OncoMed Pharmaceuticals, Inc. Anti-Cancer Stem Cell Antibody OMP-21M18 Demonstrates Potent Activity in Preclinical Studies Against Human Colon Cancer Tumors Regardless of KRAS Mutation Status

  March 2, 2011

   · 

  6 min read